System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Research Support, Non-U.S. Gov't Ppublish 29 citations

PubMed: 35674498 DOI: 10.1021/acs.jproteome.1c00977

H qNMR-Based Metabolomics Discrimination of Covid-19 Severity.

J Proteome Res 21(7):1640-1653

Authors: Banny S B Correia, Vinicius G Ferreira, Priscila M F D Piagge, Mariana B Almeida, Nilson A Assunção, Joyce R S Raimundo, Fernando L A Fonseca, Emanuel Carrilho, Daniel R Cardoso

Affiliations

  • Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos, SP 13566-590, Brazil.
  • Instituto Nacional de Ciência e Tecnologia de Bioanalítica, INCTBio, Campinas, SP 13083-861, Brazil.
  • Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, São Paulo, SP 09972-270, Brazil.
  • Faculdade de Medicina do ABC, Santo André, SP 09060-870, Brazil.
  • Faculdade de Medicina do ABC, Santo André, SP 09060-870, Brazil. Departamento de Ciências Farmacêuticas, Universidade Federal de São Paulo, Diadema, SP 09972-270, Brazil.

Abstract

The coronavirus disease 2019 (Covid-19), which caused respiratory problems in many patients worldwide, led to more than 5 million deaths by the end of 2021. Experienced symptoms vary from mild to severe illness. Understanding the infection severity to reach a better prognosis could be useful to the clinics, and one study area to fulfill one piece of this biological puzzle is metabolomics. The metabolite profile and/or levels being monitored can help predict phenotype properties. Therefore, this study evaluated plasma metabolomes of 110 individual samples, 57 from control patients and 53 from recent positive cases of Covid-19 (IgM 98% reagent), representing mild to severe symptoms, before any clinical intervention. Polar metabolites from plasma samples were analyzed by quantitative H NMR. Glycerol, 3-aminoisobutyrate, formate, and glucuronate levels showed alterations in Covid-19 patients compared to those in the control group (Tukey's HSD -value cutoff = 0.05), affecting the lactate, phenylalanine, tyrosine, and tryptophan biosynthesis and d-glutamine, d-glutamate, and glycerolipid metabolisms. These metabolic alterations show that SARS-CoV-2 infection led to disturbance in the energetic system, supporting the viral replication and corroborating with the severe clinical conditions of patients. Six polar metabolites (glycerol, acetate, 3-aminoisobutyrate, formate, glucuronate, and lactate) were revealed by PLS-DA and predicted by ROC curves and ANOVA to be potential prognostic metabolite panels for Covid-19 and considered clinically relevant for predicting infection severity due to their straight roles in the lipid and energy metabolism. Thus, metabolomics from samples of Covid-19 patients is a powerful tool for a better understanding of the disease mechanism of action and metabolic consequences of the infection in the human body and may corroborate allowing clinicians to intervene quickly according to the needs of Covid-19 patients.

MeSH

Glycerol, Signs And Symptoms, Covid-19, Metabolomics, Proteome, Prognosis, Infections, Plasma

Cited by